| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |